Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001203311-20-000120)

Filing Details

Accession Number:
0001203311-20-000120
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-04 20:51:39
Reporting Period:
2020-11-02
Accepted Time:
2020-11-04 20:51:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206199 G Daniel Welch 21823 30Th Drive Se
Bothell WA 98021		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-02 8,750 $34.25 65,348 No 4 M Direct
Common Stock Disposition 2020-11-02 8,750 $168.24 56,598 No 4 S Direct
Common Stock Acquisiton 2020-11-02 8,750 $36.70 65,348 No 4 M Direct
Common Stock Disposition 2020-11-02 8,750 $167.34 56,598 No 4 S Direct
Common Stock Acquisiton 2020-11-02 7,982 $20.06 64,580 No 4 M Direct
Common Stock Disposition 2020-11-02 7,982 $166.70 56,598 No 4 S Direct
Common Stock Acquisiton 2020-11-02 9,518 $20.06 66,116 No 4 M Direct
Common Stock Disposition 2020-11-02 9,518 $165.72 56,598 No 4 S Direct
Common Stock Acquisiton 2020-11-02 14,500 $19.02 71,098 No 4 M Direct
Common Stock Disposition 2020-11-02 14,500 $165.06 56,598 No 4 S Direct
Common Stock Disposition 2020-11-02 9,250 $164.61 47,348 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-11-02 14,500 $0.00 14,500 $19.02
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-11-02 7,982 $0.00 7,982 $20.06
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-11-02 9,518 $0.00 9,518 $20.06
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-11-02 8,750 $0.00 8,750 $34.25
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-11-02 8,750 $0.00 8,750 $36.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-05-19 No 4 M Direct
9,518 2022-05-17 No 4 M Direct
0 2022-05-17 No 4 M Direct
0 2024-05-15 No 4 M Direct
0 2023-05-17 No 4 M Direct
Footnotes
  1. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
  2. Reflects sales of common stock executed in multiple transactions at prices ranging from $167.91 to $168.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Reflects sales of common stock executed in multiple transactions at prices ranging from $166.98 to $167.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. Reflects sales of common stock executed in multiple transactions at prices ranging from $166.33 to $166.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  5. Reflects sales of common stock executed in multiple transactions at prices ranging from $165.31 to $166.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  6. Reflects sales of common stock executed in multiple transactions at prices ranging from $164.72 to $165.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  7. Reflects sales of common stock executed in multiple transactions at prices ranging from $164.49 to $164.72. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  8. Options were fully vested on 5/20/12.
  9. Options were fully vested on 5/17/13.
  10. Options were fully vested on 5/15/15.
  11. Options were fully vested on 5/16/14.